BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

747 related articles for article (PubMed ID: 18815533)

  • 1. Comparison of cancer diagnosis and treatment in Medicare fee-for-service and managed care plans.
    Riley GF; Warren JL; Potosky AL; Klabunde CN; Harlan LC; Osswald MB
    Med Care; 2008 Oct; 46(10):1108-15. PubMed ID: 18815533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Managed care enrollment and chronically disabled women with breast cancer.
    Habermann EB; Virnig BA; Durham SB; Baxter NN
    Am J Manag Care; 2008 Aug; 14(8):514-20. PubMed ID: 18690767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Do increases in the market share of managed care influence quality of cancer care in the fee-for-service sector?
    Keating NL; Landrum MB; Meara E; Ganz PA; Guadagnoli E
    J Natl Cancer Inst; 2005 Feb; 97(4):257-64. PubMed ID: 15713960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostate cancer treatment and ten-year survival among group/staff HMO and fee-for-service Medicare patients.
    Potosky AL; Merrill RM; Riley GF; Taplin SH; Barlow W; Fireman BH; Lubitz JD
    Health Serv Res; 1999 Jun; 34(2):525-46. PubMed ID: 10357289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of medicare health care delivery systems on survival for patients with breast and colorectal cancer.
    Kirsner RS; Ma F; Fleming L; Federman DG; Trapido E; Duncan R; Wilkinson JD
    Cancer Epidemiol Biomarkers Prev; 2006 Apr; 15(4):769-73. PubMed ID: 16614122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hospice use in Medicare managed care and fee-for-service systems.
    Virnig BA; Fisher ES; McBean AM; Kind S
    Am J Manag Care; 2001 Aug; 7(8):777-86. PubMed ID: 11519237
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The association of Medicare health care delivery systems with stage at diagnosis and survival for patients with melanoma.
    Kirsner RS; Wilkinson JD; Ma F; Pacheco H; Federman DG
    Arch Dermatol; 2005 Jun; 141(6):753-7. PubMed ID: 15967922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is the type of Medicare insurance associated with colorectal cancer screening prevalence and selection of screening strategy?
    Schneider EC; Rosenthal M; Gatsonis CG; Zheng J; Epstein AM
    Med Care; 2008 Sep; 46(9 Suppl 1):S84-90. PubMed ID: 18725838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of a change in Medicare reimbursement policy and HEDIS measures on stage at diagnosis among Medicare HMO and fee-for-service female breast cancer patients.
    Habermann EB; Virnig BA; Riley GF; Baxter NN
    Med Care; 2007 Aug; 45(8):761-6. PubMed ID: 17667310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Area-level variations in cancer care and outcomes.
    Keating NL; Landrum MB; Lamont EB; Bozeman SR; McNeil BJ
    Med Care; 2012 May; 50(5):366-73. PubMed ID: 22437623
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Geographic area variations in the Medicare health plan era.
    Keenan PS; Cleary PD; O'Malley AJ; Landon BE; Zaborski L; Zaslavsky AM
    Med Care; 2010 Mar; 48(3):260-6. PubMed ID: 20182269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stage at diagnosis and treatment patterns among older women with breast cancer: an HMO and fee-for-service comparison.
    Riley GF; Potosky AL; Klabunde CN; Warren JL; Ballard-Barbash R
    JAMA; 1999 Feb; 281(8):720-6. PubMed ID: 10052442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of Medicare health care systems on women with breast and cervical cancer.
    Kirsner RS; Ma F; Fleming L; Trapido E; Duncan R; Federman DG; Wilkinson JD
    Obstet Gynecol; 2005 Jun; 105(6):1381-8. PubMed ID: 15932833
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Market and beneficiary characteristics associated with enrollment in Medicare managed care plans and fee-for-service.
    Shimada SL; Zaslavsky AM; Zaborski LB; O'Malley AJ; Heller A; Cleary PD
    Med Care; 2009 May; 47(5):517-23. PubMed ID: 19365291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hospice use among Medicare managed care and fee-for-service patients dying with cancer.
    McCarthy EP; Burns RB; Ngo-Metzger Q; Davis RB; Phillips RS
    JAMA; 2003 May; 289(17):2238-45. PubMed ID: 12734135
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostate cancer outcomes among older men: insurance status comparisons results from CaPSURE database.
    Sadetsky N; Elkin EP; Latini DM; DuChane J; Carroll PR;
    Prostate Cancer Prostatic Dis; 2008; 11(3):280-7. PubMed ID: 17893700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of performance of traditional Medicare vs Medicare managed care.
    Landon BE; Zaslavsky AM; Bernard SL; Cioffi MJ; Cleary PD
    JAMA; 2004 Apr; 291(14):1744-52. PubMed ID: 15082702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surveillance testing among survivors of early-stage breast cancer.
    Keating NL; Landrum MB; Guadagnoli E; Winer EP; Ayanian JZ
    J Clin Oncol; 2007 Mar; 25(9):1074-81. PubMed ID: 17369571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparing mortality and time until death for medicare HMO and FFS beneficiaries.
    Maciejewski ML; Dowd B; Call KT; Feldman R
    Health Serv Res; 2001 Feb; 35(6):1245-65. PubMed ID: 11221818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Associations between mental health and diabetes: findings from the South Carolina Medicaid managed care program in 2006-2008.
    Lòpez-de FA; Hardin JW; Smith KL; Liu Q; Payne T; Stewart JE; Brantley V
    Ethn Dis; 2010; 20(3):239-43. PubMed ID: 20828096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.